![](/timesofindia.indiatimes.com/toiitpic/11534/images/1/db8308e9931223fe435b46abad4eabfe_1484908789685_0.jpg)
biohaven: "rimegepant pivotal phase 3 trial results -- conference call." .
1243 Used Today
318 Used Today
254 Used Today
99 Used Today
Discount $10 On Your First Purchases Of $40 Or More
77 Used Today
110 Used Today
273 Used Today
323 Used Today
biohaven: "rimegepant pivotal phase 3 trial results -- conference call." .
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv). .